Rm. 10-405A&B, Irving Institute for Clinical and Translational Research
10th Floor, Presbyterian Hospital (PH) Building, 622 W. 168th Street
Gail Geller, Johns Hopkins University
Advances in genomics are contributing to the development of more effective approaches to the prevention, treatment and control of infectious diseases (IDs). In this talk, Geller will describe the ethical, legal, and social implications (ELSIs) of recent discoveries in host and pathogen genomics relevant to HIV and Hepatitis C, paying particular attention to the needs and concerns of marginalized populations.
For further information or to convey suggestions about future speakers, contact Paul S. Appelbaum, MD, Director, Center for Research on Ethical/Legal/Social Implications of Psychiatric, Neurologic & Behavioral Genetics, Department of Psychiatry, at 646-774-8630 or firstname.lastname@example.org.
Gail Geller, ScD, MHS, is the Berman Institute’s Director of Education Initiatives and a Professor in the Department of Medicine, with joint appointments in the Department of Pediatrics and the Bloomberg School of Public Health’s Departments of Health, Behavior & Society and Health Policy & Management. She has a primary affiliation in the Berman Institute of Bioethics. She received her BS from Cornell University and her doctorate from the Johns Hopkins School of Public Health with concentrations in bioethics and social and behavioral sciences. Dr. Geller has been an active member of the ELSI (Ethical, Legal & Social Implications of Genetics) research community since its inception. For over 25 years, she has conducted empirical research – both quantitative and qualitative – on the ethical and social implications of genetic testing in the adult, pediatric and family contexts. Currently, she is Co-Principal Investigator of an NHGRI CEER (Center of Excellence in ELSI Research) designed to address the ELSI issues arising from the application of genomics to the prevention and treatment of infectious diseases. She has been a member of two NIH Consortia: the Cancer Genetics Studies Consortium and the Informed Consent Consortium, and co-chaired the Task Force on Informed Consent for Cancer Susceptibility Testing
This event is sponsored by the Center for Research on Ethical/Legal/Social Implications of Psychiatric, Neurologic & Behavioral Genetics, and the Department of Psychiatry, Columbia University Medical Center. This seminar is part of the Seminar on Ethical, Legal and Social Implications of Genetics series.